September 21, 2025 - 05:03

On Thursday, Pennsylvania Governor Josh Shapiro called out former Vice President Kamala Harris, stating that she must address why she did not voice any concerns regarding President Joe Biden's health prior to the upcoming 2024 election. Shapiro's comments come amid ongoing debates about Biden's age and fitness for office as he seeks re-election.
The governor emphasized the importance of transparency in leadership, particularly as voters prepare to make critical decisions about the nation's future. He argued that Harris, as a prominent figure in the Democratic Party and a close ally of Biden, has a responsibility to clarify her stance on these pressing issues.
Shapiro's remarks reflect a growing sentiment among some political observers who believe that the health and vitality of candidates should be openly discussed, especially in light of the significant challenges facing the country. As the election approaches, the pressure is mounting for Harris and other Democratic leaders to address these concerns head-on.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....